AllPennyStocks.com Media, Inc.

All Penny Stocks.com Announces Corporate Write-Up on Nuvilex, Inc. (OTCQB:NVLX)

 
Repost This

Mississauga, ON -- (SBWIRE) -- 12/16/2013 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com), a leading penny stock / small-cap information site, released its latest spotlight company Nuvilex, Inc. (OTCQB:NVLX).

Nuvilex is a biotechnology company with the rights to a novel cellulose-based, live-cell encapsulation technology, called Cell-in-a-Box™, that will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer and diabetes are being built. The Company's treatment for pancreatic cancer involves the use of the widely used anticancer prodrug, ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or "cancer-killing" form. Nuvilex's subsidiary, Medical Marijuana Sciences, Inc., is dedicated to the development of cancer treatments based upon the well-known chemical constituents of marijuana. Nuvilex is exploring ways in which the Cell-in-a-Box™ technology may play a role in these efforts.

The proprietary Cell-in-a-Box™ cellulose-based live-cell encapsulation technology is a way to protect living cells during and after implantation in the body. Through the use of this platform technology the therapeutic efficacy of drugs for hard-to-treat diseases such as cancer may be improved and treatments for diabetes may be developed.

Pre-clinical and clinical research has documented that the Cell-in-a-Box™ capsules and the live cells within them are well tolerated by patients and can be administered without immunosuppressive drugs because of the unique nature of the capsules. Data shows that even after two years in the body, the living cells inside the capsules are still alive and functioning normally.

A complete NVLX profile can be viewed at: http://www.allpennystocks.com/aps_us/company_spotlights/archives/nvlx.asp

About AllPennyStocks.com Media Inc.
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and U.S. site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs a unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, Nasdaq and OTCBB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.

Contact
AllPennyStocks.com Media, Inc.
Peter Szafranski - President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has been compensated five thousand five hundred dollars by a third-party, Berkshire Capital Management Co., Inc. for its efforts in presenting the NVLX profile on its web site and distributing it to its database of subscribers as well as other services. A full disclaimer on NVLX can be found at: http://www.allpennystocks.com/aps_us/company_spotlights/archives/nvlx.asp.